Lincoln Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 1,559.88 million compared to INR 1,406.12 million a year ago. Revenue was INR 1,646.83 million compared to INR 1,463.34 million a year ago. Net income was INR 276.54 million compared to INR 237.13 million a year ago. Basic earnings per share from continuing operations was INR 13.81 compared to INR 11.84 a year ago. Diluted earnings per share from continuing operations was INR 13.81 compared to INR 11.84 a year ago.
For the six months, sales was INR 2,916.07 million compared to INR 2,640.83 million a year ago. Revenue was INR 3,079.93 million compared to INR 2,762.99 million a year ago. Net income was INR 466.68 million compared to INR 387.25 million a year ago. Basic earnings per share from continuing operations was INR 23.3 compared to INR 19.33 a year ago. Diluted earnings per share from continuing operations was INR 23.3 compared to INR 19.33 a year ago.